Asunto(s)
Calcinosis , Ombligo , Humanos , Calcinosis/diagnóstico , Calcinosis/patología , Ombligo/patología , Femenino , Enfermedades de la PielRESUMEN
Non-neural granular cell tumor was first described in 1991 as an unusual primitive, polypoid variant of the conventional granular cell tumor. To date, this neoplasm remains a rare entity and the cell of origin is uncertain. While the histological features are similar to the conventional granular cell tumor, it represents a distinct entity that is negative for S100 and lacks true nerve sheath differentiation. Here, we describe a case of a 4-year-old male who presented with a painless, soft nodule on his right chest wall that was slowly increasing in size. The mass was excised and sent for pathologic analysis. Microscopic examination reveals spindle and epithelioid cells with vesicular nuclei and prominent granular eosinophilic cytoplasm. Immunohistochemical analysis shows negative staining for S100 and AE1/AE3/PCK26 but is positive for CD68. A diagnosis of a non-neural granular cell tumor was made. We report a rare and diagnostically challenging case in a pediatric patient.
RESUMEN
We present a series of 25 cases of basal cell carcinoma (BCC) with overlying cytologically bland epidermal hyperplasia and cyst formation. Eight of the BCCs were nodular and 11 were infiltrative. Immunohistochemical staining for Ki-67 and cytokeratin 17 (CK17) was performed to evaluate the proliferative and differentiation characteristics of the hyperplastic epithelium compared with the adjacent BCC and normal epidermis. Fourteen of the 25 cases had sufficient tissue to evaluate the staining patterns. In the majority of cases, Ki-67 expression was prominent throughout the BCCs, but only expressed in the basal and suprabasal layers of the adjacent hyperplastic epithelium, which was equivalent to normal epidermis. CK17 expression was prominent throughout the BCC and surrounding incident hair follicles. CK17 was expressed to a lesser extent in the central more keratinized portions of the hyperplastic epithelium, but rarely in normal epidermis. The morphologic characteristics and immunohistochemical staining patterns in these tumors suggest that the epidermal hyperplasia represents pseudocarcinomatous hyperplasia with follicular differentiation. Recognizing this pattern of epidermal change should alert the pathologist to the possibility of an associated BCC in cases in which the biopsy specimen or sectioning is initially too superficial to reveal the underlying malignancy.
Asunto(s)
Carcinoma Basocelular/patología , Neoplasias Cutáneas/patología , Adulto , Anciano , Anciano de 80 o más Años , Biomarcadores de Tumor/análisis , Carcinoma Basocelular/metabolismo , Diferenciación Celular , Quistes/metabolismo , Quistes/patología , Femenino , Humanos , Hiperplasia/metabolismo , Hiperplasia/patología , Inmunohistoquímica , Masculino , Persona de Mediana Edad , Neoplasias Cutáneas/metabolismoRESUMEN
BACKGROUND: Dermatopathologists often are asked by clinicians to report margins on punch excisions of melanocytic lesions. OBJECTIVE: We sought to determine the adequacy of surgical margins on melanocytic lesions submitted with intention of complete excision using punch removal technique. METHODS: We conducted prospective analysis of surgical margins on 266 consecutive patients who underwent attempted complete removal of 405 melanocytic nevi submitted as punch and fusiform excisions. RESULTS: Of 206 nonbisected punch excisions, 127 (62%) had final positive margins. Of 159 bisected punch excisions, 76 (48%) had final positive margins. Of 40 elliptical excisions, two (5%) had final positive margins. LIMITATIONS: Information on the perilesional rim of nonpigmented skin included in the excision was not available. CONCLUSIONS: Of punch excisions, 56% had positive margins. Importantly, 30% of these punch excised specimens were negative on initial levels but had positive margins after extensive sectioning, affirming that fusiform excisions are the preferred method to evaluate margins in melanocytic lesions.
Asunto(s)
Nevo Pigmentado/patología , Nevo Pigmentado/cirugía , Neoplasias Cutáneas/patología , Neoplasias Cutáneas/cirugía , Piel/patología , Humanos , Estudios Prospectivos , Procedimientos Quirúrgicos Operativos/métodosAsunto(s)
Histiocitoma Fibroso Benigno/metabolismo , Histiocitoma Fibroso Benigno/patología , Enfermedades de la Piel/metabolismo , Enfermedades de la Piel/patología , Neoplasias Cutáneas/patología , Xantomatosis/metabolismo , Xantomatosis/patología , Colágeno Tipo I/biosíntesis , Humanos , Inmunohistoquímica , Neprilisina/biosíntesis , Neoplasias Cutáneas/metabolismoAsunto(s)
Errores Diagnósticos/prevención & control , Melanocitos/patología , Melanoma/diagnóstico , Nevo de Células Epitelioides y Fusiformes/diagnóstico , Biopsia del Ganglio Linfático Centinela , Neoplasias Cutáneas/diagnóstico , Proliferación Celular , Diagnóstico Diferencial , Humanos , Melanoma/secundarioRESUMEN
The effects of various laser wavelengths and fluences on the fungal isolate, Trichophyton rubrum, were examined in vitro. Standard-size isolates of T. rubrum were irradiated by using various laser systems. Colony areas were compared for growth inhibition on days 1, 3, and 6 after laser irradiation. Statistically significant growth inhibition of T. rubrum was detected in colonies treated with the 1,064-nm Q-switched Nd:YAG laser at 4 and 8 J/cm(2) and 532-nm Q-switched Nd:YAG laser at 8 J/cm(2). Q-switched Nd:YAG laser at 532- and 1,064-nm wavelengths produced significant inhibitory effect upon the fungal isolate T. rubrum in this in vitro study. However, more in vitro and in vivo studies are necessary to investigate if lasers would have a potential use in the treatment of fungal infections of skin and its adnexa.
Asunto(s)
Arthrodermataceae/efectos de la radiación , Recuento de Colonia Microbiana , Terapia por Láser , Láseres de Estado Sólido , Rayos Láser , Tiña/terapia , Trichophyton/efectos de la radiación , Técnicas In Vitro , Quinonas , SesquiterpenosRESUMEN
Low-grade fibromyxoid sarcoma is an uncommon, deceptively bland mesenchymal neoplasm that typically occurs in the deep soft tissues of the proximal extremities of young to middle-aged patients. Intra-abdominal low-grade fibromyxoid sarcomas are distinctly rare. We describe the first reported example of this sarcoma involving the ovary. The 42-year-old patient presented with progressing abdominal pain and urinary frequency. Computed tomographic imaging of the abdomen and pelvis showed a 14-cm left-sided pelvic mass. The patient underwent surgical resection and, intraoperatively, a left ovarian mass was identified that extended to both the left hypogastric artery and the left ureter. The resected specimen consisted of a 17-cm tan, fleshy mass containing grossly recognizable nodules of gelatinous, myxoid tissue and a small rim of normal ovary. Microscopic examination of the neoplasm revealed a cytologically bland spindle cell proliferation set in a collagenized stroma that abruptly transitioned to nodules of a myxoid stroma with a well-formed capillary vasculature, features characteristic of low-grade fibromyxoid sarcoma. On the basis of the diagnosis, the patient was clinically staged as a retroperitoneal sarcoma with secondary ovarian involvement. The patient has stable residual disease 11 months postoperatively. This case adds to the literature of intra-abdominal low-grade fibromyxoid sarcoma and expands the list of malignant mesenchymal neoplasms that may involve the ovary.
Asunto(s)
Fibroma/diagnóstico , Neoplasias Ováricas/diagnóstico , Neoplasias Retroperitoneales/diagnóstico , Sarcoma/diagnóstico , Adulto , Diagnóstico Diferencial , Femenino , Fibroma/patología , Humanos , Neoplasias Ováricas/patología , Neoplasias Retroperitoneales/patología , Sarcoma/patologíaRESUMEN
BACKGROUND: Injection site reactions are well recognized in patients treated with etanercept. Previous reports describe histologic findings of a cell-mediated T(H)1 reaction, with CD8+ T cells composing the majority of the dermal infiltrate. OBSERVATIONS: A pruritic, erythematous, edematous patch occurred on the right thigh of a 57-year-old white woman treated for rheumatoid arthritis within 12 to 24 hours after her second dose of subcutaneous etanercept. The patient had a similar reaction to adalimumab injection 2 weeks prior to presentation. While benzyl alcohol is present in the etanercept preparation, and mannitol in both drugs, dermal injection revealed no reaction to these additives. Biopsy specimens from the etanercept injection site demonstrated papillary dermal edema accompanied by a brisk polymorphous infiltrate with a predominance of eosinophils and scattered flame figures. CONCLUSIONS: Histologic features of eosinophilic cellulitis as a response to etanercept have not been reported to date. Although most injection site reactions contain T cells and represent a T(H)1 immune response, the findings we report suggest a T(H)2-mediated phenomenon.
Asunto(s)
Antirreumáticos/efectos adversos , Celulitis (Flemón)/inducido químicamente , Eccema/inducido químicamente , Eosinofilia/inducido químicamente , Inmunoglobulina G/efectos adversos , Proteínas Recombinantes de Fusión/efectos adversos , Antirreumáticos/administración & dosificación , Artritis Reumatoide/tratamiento farmacológico , Biopsia , Celulitis (Flemón)/patología , Diagnóstico Diferencial , Eccema/patología , Eosinofilia/patología , Etanercept , Femenino , Humanos , Inmunoglobulina G/administración & dosificación , Inyecciones Subcutáneas , Persona de Mediana Edad , Receptores del Factor de Necrosis Tumoral/administración & dosificación , Proteínas Recombinantes de Fusión/administración & dosificación , Piel/patologíaAsunto(s)
Enfermedades en Gemelos/genética , Hamartoma/genética , Cuero Cabelludo/patología , Glándulas Sebáceas/patología , Enfermedades de la Piel/genética , Niño , Enfermedades en Gemelos/patología , Hamartoma/patología , Humanos , Masculino , Enfermedades de la Piel/patología , Gemelos DicigóticosRESUMEN
BACKGROUND: The evaluation of malignant cutaneous spindle cell tumors is challenged by a diagnostic differential that comprises neoplasms of diverse histogenesis, and a broad immunohistochemical panel may confound the diagnosis when the results suggest multiple lines of differentiation, such as with a combined myofibroblastic and epithelial phenotype. METHODS: We report the case of a solitary scalp nodule that quickly became locally metastatic. A comprehensive panel of immunohistochemistry markers and electron microscopy was evaluated to determine the differentiation of the spindle cells. RESULTS: The tumor, consisting of wavy and slender spindle cells with predominantly bland nuclei, showed immunoreactivity to vimentin, smooth muscle actin, and muscle-specific actin. AE1/AE3, CK5/6, and MNF-116 antibodies were weakly positive in rare cells. However, 34betaE12 showed diffuse positivity in the spindle cell population, thus supporting the diagnosis of a sarcomatoid carcinoma with myofibroblastic differentiation. CONCLUSIONS: The use of 34betaE12 is essential for the evaluation of myofibroblastic spindle cell tumors with rare cytokeratin reactivity. However, even with immunohistochemical and electron microscopic studies, the diagnosis of spindle cell tumors can be confounded by the multiplicity of nosologic equivalents, such as carcinosarcoma, spindle cell carcinoma, and metaplastic carcinoma. The nomenclature of these spindle cell tumors is discussed.